demiol. 1997. Vol. 7. P. 383-395.
46. ??Valentijn T.M., Galal W., Tjeertes E.K. et al. The obesity paradox in the surgical population / / Surgeon. 2013. Vol.11 (3). P.169-176.
47. Strandberg TE, Strandberg AY, Salomaa VV et al. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men / / Eur. Heart J. 2009. Vol.30 (14). P. 1720-1727.
48. Strandberg T.E., Stenholm S., Strandberg A.Y. et al. The «Obesity Paradox,» Frailty, Disability, and Mortality in Older Men: A Prospective, Longitudinal Cohort Study / / Am. J. Epidemiol. 2013.
49. Носков С., Шеріна Т., Пряничникова А. Про позитивну роль ожиріння в клініці внутрішніх хвороб / / Лікар. 2013. № 4. С. 13-17.
50. Драпкіна О.М., Дікур О.М. Надмірна вага і брак маси тіла: між Сциллою і Харибдою / / Артеріальна гіпертензія. 2009. № 5. С. 633-639.
51. Arnl? V J., Ingelsson E., Sundstr? M J., Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men / / Circulation. 2010.Vol. 121 (2). P. 230-236.
52. Zafrir B., Adir Y., Shehadeh W. et al. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the «obesity paradox» / / Respir. Med. 2013. Vol. 107 (1). P. 139-146.
53. Kramer CK, Zinman B., Retnakaran R. Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta-analysis / / Ann. Intern. Med. 2013. Vol. 159 (11). P. 758-769.
54. Yanovski S.Z., Yanovski J.A. Long-term Drug Treatment for Obesity A Systematic and Clinical Review Published online November 14, 2013.
55. Thomsen M., Nordestgaard B.G. et al. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome / / JAMA Intern. Med. 2013.
56. Coutinho T., Goel K., Corr? A de S? D. et al. Combining Body Mass Index With Measures of Central Obesity in the Assessment of Mortality in Subjects With Coronary Disease: Role of «Normal Weight Central Obesity» / / J. Am. Coll. Cardiol. 2013. Vol. 61 (5). P. 553-560.
57. Lavie C.J., Milani R.V., Artham S.M. et al. The obesity paradox, weight loss, and coronary disease / / Am. J. Med. 2009. Vol. 122 (12). P. 1106-1114.
58. Padwal R.S., Rucker D., Li S.K. et al. Long-term drug pharmacotherapy for obesity and overweight January 21, 2009 summaries.cochrane.org/CD004094/
59. Norris S.L., Zhang X., Avenell A. et al. Long-term non-pharmacological weight loss interventions for adults with prediabetes January 21, 2009 summaries.cochrane.org/CD005270/
60. Tran PT, Thomas A. Summary minutes of the Endocrinologic and Metabolic Drugs Advisory Committee meeting March 28-29, 2012. Http://fda.gov/downloads/AdvisoryCommittees
Для підготовки даної роботи були використані матеріали з сайту рмж.рф
Дата додавання: 20.03.2014
